+1.62%

S&O 500 5,382.45

-0.47%

US 10 400

+2.28%

Nasdaq 16,565.41

+2.28%

Crude Oil 16,565.41

-0.27%

FTSE 100 8,144.87

+1.06%

Gold 2,458.10

-0.53%

Euro 1.09

+0.36%

Pound/Dollar 1.27

Sunday, October 11, 2026

Business News

Mirum Pharmaceuticals to share phase 3 LIVMARLI study results

by marketdash October 11, 2026

by marketdash October 11, 2026 0 comments

Get New Updates nto Take Care Your Pet

Discover the art of creating a joyful and nurturing environment for your beloved pet.

Will be used in accordance with our Privacy Policy

Most read

Amazon in talks to buy AI startup Decart for around $7 billion, WSJ reports

October 11, 2026

Mirum Pharmaceuticals to share phase 3 LIVMARLI study results

October 11, 2026

First Commonwealth EVP/CFO James Reske disposes of $42,512 in stock

October 11, 2026

@ 2024 – Marketdash – All Rights Reserved.